Experimental - This project is still in development, and not ready for the prime time. A minimal, secure Python interpreter written in Rust for use by AI. Monty avoids the cost, latency, complexity ...
COBOL is in the headlines again, and this time it is because of artificial intelligence (AI) – sparking conversations with tools emerging that claim t.
As if we didn’t need more reasons to get rid of the GIL, this deep-dive analysis demonstrates how to use process-based async to work around the GIL when training models with PyTorch. No word about use ...
How to use Rust with Python, and Python with Rust Oldie but goodie: Get started with the PyO3 project, for merging Python’s convenience with Rust’s speed. Python news bites Wasmer beefs up Python ...
Houston journalist Kate Murphy discusses the science behind human connection, which she delves into in her new book, “Why We Click.” Let's face it: the Internet age has been a dual-edge sword. Social ...
A few years ago, during a taxi ride, the driver described to me how a pig had transformed his life. A childhood with dogs taught him what to expect from animals, yet he was unprepared for the pig he ...
Women gather at a neighborhood square in Lilongwe, Malawi, on June 8 Women gather at a neighborhood square in Lilongwe, Malawi, on June 8Zafer Goder—Anadolu/Getty Images In Malawi, one in three women ...
Exclamation marks, ellipses and ‘haha’ can’t fix our growing inability to communicate. By Nitsuh Abebe “How Many Exclamation Points Are Too Many in an Email? A Psychologist Weighs In.” A psychologist!
This is a review of Truth: What It Is, How To Find It & Why It Still Matters. by Michael Shermer, forthcoming from Johns Hopkins University Press. Amidst claims of “fake news,” “alternative facts,” ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Recursion Pharmaceuticals, Inc. before investing. In this article, we go over a ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...